Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low

Gut

Volumn 47, Issue 4, 2000, Pages 514-519

  Farrell, R J ^a   Ang, Y ^a   Kileen, P ^a   O'Briain, D S ^a   Kelleher, D ^a   Keeling, P W N ^a   Weir, D G ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

Azathioprine; Cyclosporin; Immunosuppressive therapy; Inflammatory bowel disease; Methotrexate; Non Hodgkin's lymphoma

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER RISK; DISEASE ASSOCIATION; ENTERITIS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SEX RATIO;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COLONIC DISEASES, FUNCTIONAL; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INTESTINAL NEOPLASMS; IRELAND; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 0033795223     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.47.4.514     Document Type: Article

References (49)

1. 1 Hoover R, Fraumeni JF. Risk of cancer in renal-transplant recipients. Lancet 1973,ii:55-7.
2. 2 Kinlen LJ, Sheil AGR, Peto J, et al. Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. BMJ 1979;ii:1461-6.
3. 3 Greenstein AJ, Gennuso R, Sachar DB, et al. Extraintestinal cancers in inflammatory bowel disease. Cancer 1985;56: 2914-21.
4. 4 Shepherd NA, Hall PA, Williams GT, et al. Primary malignant lymphoma of the large intestine complicating chronic inflammatory bowel disease. Histopathology 1989;15:325-37.
5. 5 Renton P, Blackshaw AJ. Colonic lymphoma complicating ulcerative colitis. Br J Surg 1976;63:542-5.
6. 6 Wychulis AR, Beahrs OH, Woolner LB. Malignant lymphoma of the colon. A study of 69 cases. Arch Surg 1966;93:215-25.
7. 7 Ekbom A, Helmick C, Zack M, et al. Extracolonic malignancies in inflammatory bowel disease. Cancer 1991; 67:2015-19.
8. 8 Persson PG, Karlen P, Bernell O, et al. Crohn's disease and cancer: a population based cohort study. Gastroenterology 1994;107:1675-79.
9. 9 Loftus EV, Sandborn WJ, Tremaine WJ, et al. Risk of lymphoma in inflammatory bowel disease: a population estimate. Gastroenterology 1998;114:A1024.
10. 10 Connell WR, Kamm MA, Dickson, et al. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 1994;343:1249-52.
11. 11 Lemann M, Bonhomme P, Bitoun A, et al. Treatment of Crohn's disease with azathioprine or 6-mercaptopurine. Retrospective study of 126 cases. Gastroenterol Clin Biol 1990;14:548-54.
12. 12 Present DH, Meltzer SJ, Krumholz MP, et al. 6-Mercaptopurine in the management of inflammatory bowel disease: Short-and long-term toxicity. Ann Intern Med 1989;111:641-49.
13. 13 Kinlen LJ. Immunologic factors, including AIDS. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention, 2nd edn. New York: Oxford University Press, 1996:532-45.
14. 14 Bouhnik Y, Lemann M, Mary JY, et al. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet 1996;347:215-19.
15. 15 Bickston SJ, Lichtenstein GR, Arseneau KO, et al. The relationship between infliximab treatment and lymphoma in Crohn's disease. Gastroenterology 1999;117:1433-7.
16. 16 Cancer in Ireland. 1995 incidence and mortality. National Cancer Registry of Ireland, 1996.
17. 17 Edwards FC, Truelove SG. The course and prognosis of ulcerative colitis. Gut 1964;5:1-22.
18. 18 Ekbom A, Helmick E, Zack M, et al. Ulcerative colitis and colorectal cancer. A population based study. N Engl J Med 1990;323:1228-33.
19. 19 Greenstein AJ, Mullin GE, Strauchen JA, et al. Lymphoma in inflammatory bowel disease. Cancer 1992;69:1119-23.
20. 20 Caspi O, Polliack A, Klar R, et al. The association of inflammatory bowel disease and leukemia - coincidence or not? Leuk Lymphoma 1995;17:255-62.
21. 21 Bargen JA. Chronic ulcerative colitis associated with malignant disease. Arch Surg 1928;93:1307-11.
22. 22 Lenzen R, Borchard F, Lubke H, et al. Colitis ulcerosa complicated by malignant lymphoma: case report and analysis of published works. Gut 1995;36:306-10.
23. 23 Shetty K, Rybicki L, Brzezinski A, et al. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 1999;94:1643-9.
24. 24 Schattner A, Kozak N, Lassry Y, et al. Primary intestinal T-cell lymphoma and sclerosing cholangitis: a cytokine-mediated association? J Intern Med 1998;244:537-41.
25. 25 Cornes JS, Smith JC, Southwood WFW. Lymphosarcoma in chronic ulcerative colitis with report of two cases. Br J Surg 1961;49:50-3.
26. 26 Sataline LR, Mosley EM, Kirkham W. Ulcerative colitis complicated by colonic lymphoma. Gastroenterology 1962; 44:342-7.
27. 27 Isomaki HA, Hakulinen T, Joutsenlahti U. Excess risk of lymphoma, leukemia, and myeloma in patients with rheumatoid arthritis. J Chronic Dis 1978;31:691-6.
28. 28 Gridley G, McLaughlin JK, Ekbom A, et al. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993;85:307-11.
29. 29 Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1972;29:252-60.
30. 30 Loehr WJ, Mujahed Z, Zahn FD, et al.. Primary lymphoma of the gastrointestinal tract: a review of 100 cases. Ann Surg 1969;170:232-8.
31. 31 Dragosics B, Bauer P, Radaszikiewicz T. Primary gastrointestinal non-Hodgkin's lymphomas. A retrospective clinico-pathological study of 150 cases. Cancer 1985;55: 1060-73.
32. 32 Friedman HB, Silver GM, Brown CH. Lymphoma of the colon simulating ulcerative colitis: report of four cases. Am J Dig Dis 1968;13:910-17.
33. 33 Robert ME, Kuo FC, Longtine JA, et al. Diffuse colonic mantle cell lymphoma in a patient with presumed ulcerative colitis. Am J Surg Pathol 1996;20:1024-31.
34. 34 Son HJ, Rhee PL, Kim JJ, et al. Primary T-cell lymphoma of the colon. Korean J Int Med 1997;12:238-41.
35. 35 Gelb A, Zalusky R. Lymphoma in Crohn's disease occurring in a patient on 6-MP. Am J Gastroenterol 1983;78:316.
36. 36 Kingsmore SF, Hall BD, Allen NB, et al. Association of methotrexate, rheumatoid arthritis and lymphoma: Report of 2 cases and literature review. J Rheum 1992;19:1462-5.
37. 37 Kinlen LJ. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment. Am J Med 1985;78(suppl 1a):44-9.
38. 38 Jones M, Symmons D, Finn J, et al. Does exposure to immunosuppressive therapy increase the 10 year malignancy and mortality risks in rheumatoid arthritis? A matched cohort study. Br J Rheum 1996;35:738-45.
39. 39 Ziegler JL, Beckstead JA, Volberding PA, et al. Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 1984;311:565-70.
40. 40 Burkes RL, Meyer PR, Gill PS, et al. Rectal lymphoma in homosexual men. Arch Intern Med 1986;29:413-16.
41. 41 Das KM, Valenzuela I, Morecki R. Crohn disease lymph node homogenates produce murine lymphoma in athymic mice. Proc Natl Acad Sci USA 1980;77:588-92.
42. 42 Cleary GL, Warnke R, Sklar J. Monoclonality of lympho-proliferative lesions in cardiac transplant recipients. N Engl J Med 1984;310:477-82.
43. 43 Hussell T, Isaacson PG, Crabtree JE, et al. The response of cells from low grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1993;342:571-4.
44. 44 Sandborn WJ. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate. Am J Gastroenterol 1996;91:423-33.
45. 45 Cockburn IT, Krupp P. The risk of neoplasms in patients treated with cyclosporine A. J Autoimmun 1989;2:723-31.
46. 46 Ellman MH, Hurwitz H, Thomas C, et al. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 1991;18:1741-3.
47. 47 Bailin PL, Tindall JP, Roenigk HH, et al. Is methotrexate therapy for psoriasis carcinogenic? JAMA 1975;232:359-62.
48. 48 Kamel OW, Van de Rijn M, Weissl M, et al. Reversible lymphoma associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 1993;328:1317-21.
49. 49 Stein CM, Pincus T, Yocum D, et al. Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks: an open-label extension study. The Methotrexate-Cyclosporine Combination Study Group. Arthritis Rheum 1997;40:1843-51.